Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: A nested case-control study

Rheumatology (United Kingdom)

Volumn 55, Issue 2, 2015, Pages 367-376

  Gan, Ryan W ^a   Young, Kendra A ^a   Zerbe, Gary O ^a   Kristen Demoruelle, M ^b   Weisman, Michael H ^c   Buckner, Jane H ^d   Gregersen, Peter K ^e   Mikuls, Ted R ^f   O'Dell, James R ^f   Keating, Richard M ^g   Clare Salzler, Michael J ^h   Deane, Kevin D ^b   Michael Holers, V ^b   Norris, Jill M ^a  

^a Global Health and Health Disparities   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

^e FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g SCRIPPS HEALTH   (United States)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoantibodies; Epidemiology; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; FEMALE; FIRST DEGREE RELATIVE; HUMAN; MALE; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SELF REPORT; ARTHRITIS, RHEUMATOID; BLOOD; CLINICAL TRIAL; FOLLOW UP; HEALTH SURVEY; IMMUNOLOGY; INCIDENCE; MULTICENTER STUDY; PROSPECTIVE STUDY; UNITED STATES;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84961904779     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev266     Document Type: Article

References (50)

1. Deane KD, Norris JM, Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. Rheum Dis Clin N Am 2010;36:213-41.
2. Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol 2014;10:212-28.
3. Whiting PF. Systematic review: accuracy of anticitrullinated peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 2010;152:456-64.
4. Rantapää-Dahlqvist S, de Jong BAW, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
5. Deane KD, O'Donnell CI, Hueber W et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 2010;62:3161-72.
6. Nielen MMJ, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
7. Vallbracht I, Rieber J, Oppermann M et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004;63:1079-84.
8. Van Venrooij WJ, van Beers JJBC, Pruijn GJM. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011;7:391-8.
9. Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol 2013;9:141-53.
10. De Vries R. Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 2011;23:227-32
11. Miller FW, Alfredsson L, Costenbader KH et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012;39:259-71.
12. Harbige LS. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003;38:323-41.
13. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation:dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61.
14. Norris JM, Yin X, Lamb MM et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 2007;298:1420-8.
15. Norris JM, Kroehl M, Fingerlin TE et al. Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young. Diabetologia 2014;57:295-304.
16. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83:1505S_19S.
17. Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 2013;75:645-62
18. Kris-Etherton PM, Taylor DS, Yu-Poth S et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71:179S-88S.
19. Linos A, Kaklamanis E, Kontomerkos A et al. The effect of olive oil and fish consumption on rheumatoid arthritis-a case control study. Scand J Rheumatol 1991;20:419-26.
20. Linos A, Kaklamani VG, Kaklamani E et al. Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? Am J Clin Nutr 1999;70:1077-82
21. Benito-Garcia E, Feskanich D, Hu FB et al. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 2007;9:R16.
22. Rosell M, Wesley A-M, Rydin K et al. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009;20:896-901.
23. Pedersen M, Stripp C, Klarlund M et al. Diet and risk of rheumatoid arthritis in a prospective cohort. J Rheumatol 2005;32:1249-52.
24. Shapiro JA, Koepsell TD, Voigt LF et al. Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. Epidemiology 1996;7:256-63.
25. Di Giuseppe D, Wallin A, Bottai M et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis 2014;73:1949-53.
26. Lee AL, Park Y. The association between n-3 polyunsaturated fatty acid levels in erythrocytes and the risk of rheumatoid arthritis in Korean women. Ann Nutr Metab 2013;63:88-95.
27. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
28. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
29. Burton PR, Clayton DG, Cardon LR et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
30. Kolfenbach JR, Deane KD, Derber LA et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum 2009;61:1735-42.
31. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA: Wolters Kluwer Health/ Lippincott Williams & Wilkins, 2008: 171_82.33.Stürmer T, Brenner H. Degree of matching and gain in power and efficiency in case-control studies. Epidemiology 2001;12:101-8.
32. Friedlander Y, Merom DL, Kark JD. A comparison of different matching designs in case-control studies: an empirical example using continuous exposures, continuous confounders and incidence of myocardial infarction. Stat Med 1993;12:993-1004.
33. Stürmer T, Brenner H. Degree of matching and gain in power and efficiency in case-control studies. Epidemiology 2001;12:101-8.
34. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
35. Karlson EW, Chang S-C, Cui J et al. Gene_environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2009;69:54-60.
36. R Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. http://www.R-project.org/ (11 July 2015, date last accessed)
37. Papanikolaou Y, Brooks J, Reider C et al. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003_2008. Nutr J 2014;13:31.
38. Flock MR, Skulas-Ray AC, Harris WS et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose_response randomized controlled trial. J Am Heart Assoc 2013;2:e000513_e000513.
39. Vidgren HM, Agren JJ, Schwab U et al. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997;32:697-705.
40. Brustad M, Braaten T, Lund E. Predictors for cod-liver oil supplement use - the Norwegian Women and Cancer Study. Eur J Clin Nutr 2004;58:128-36.
41. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
42. Arlestig L, Mullazehi M, Kokkonen H et al. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis 2012;71:825-29.
43. El-Gabalawy HS, Robinson DB, Hart D et al. Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 2009;36:1130-35.
44. Barra L, Scinocca M, Saunders S et al. Anticitrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: ACPAs in firstdegree relatives of RA patients. Arthritis Rheum 2013;65:1439-47.
45. Terao C, Ohmura K, Ikari K et al. Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population. Arthritis Care Res 2014;66:1818-27.
46. Svendsen AJ, Hjelmborg JV, Kyvik KO et al. The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs. J Autoimmun 2013;41:120-5.
47. Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune disease and related conditions. Arthritis Rheum 2009;60:661-8.
48. Helmick CG, Felson DT, Lawrence RC et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008;58:12-25.
49. Hughes-Austin JM, Deane KD, Derber LA et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2013;72:901-7.
50. Sokolove J, Bromberg R, Deane KD et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012;7:e35296.